| Data | Hora | Fonte | Título | Código | Companhia |
| 20/04/2017 | 07:04 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 13/03/2017 | 17:37 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 06/03/2017 | 08:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 02/03/2017 | 17:57 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 02/03/2017 | 17:51 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 01/03/2017 | 19:04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 01/03/2017 | 18:50 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 01/03/2017 | 11:52 | PR Newswire (US) | Lilly Completes Acquisition of CoLucid Pharmaceuticals | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 01/03/2017 | 11:41 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 01/03/2017 | 08:31 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 01/03/2017 | 08:18 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 14/02/2017 | 14:15 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 10/02/2017 | 19:32 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 02/02/2017 | 19:54 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 31/01/2017 | 16:32 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 31/01/2017 | 16:17 | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 27/01/2017 | 18:14 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 19/01/2017 | 06:02 | Dow Jones News | Business Watch -- WSJ | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 18/01/2017 | 19:52 | Edgar (US Regulatory) | Written Communication Relating to an Issuer or Third Party (sc To-c) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 18/01/2017 | 18:31 | PR Newswire (US) | Harwood Feffer LLP Announces Investigation of CoLucid Pharmaceuticals, Inc. | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 18/01/2017 | 11:19 | Edgar (US Regulatory) | Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 18/01/2017 | 10:54 | Dow Jones News | Eli Lilly to Buy Migraine Drug Developer CoLucid Pharmaceuticals | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 18/01/2017 | 10:03 | PR Newswire (US) | Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 28/11/2016 | 16:59 | GlobeNewswire Inc. | CoLucid Pharmaceuticals to Present at the 28th Annual Piper Jaffray Healthcare Conference | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 14/11/2016 | 11:00 | GlobeNewswire Inc. | CoLucid Pharmaceuticals Provides SPARTAN Enrollment Update | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 09/11/2016 | 11:03 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 09/11/2016 | 11:00 | GlobeNewswire Inc. | CoLucid Pharmaceuticals Announces 2016 Third Quarter Results and Corporate Highlights | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 08/11/2016 | 11:00 | GlobeNewswire Inc. | CoLucid Pharmaceuticals to Present at the Stifel 2016 Healthcare Conference | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 05/10/2016 | 11:54 | GlobeNewswire Inc. | CoLucid Pharmaceuticals Announces Additional Analyses of Lasmiditan’s Onset of Action Data from SAMURAI and Supporting Non-... | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 26/09/2016 | 08:00 | GlobeNewswire Inc. | CoLucid Pharmaceuticals to Present at the Ladenburg Thalmann 2016 Healthcare Conference | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |